Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Ectopic pregnancy and miscarriage: diagnosis and initial management

NICE guideline
Reference number: NG126
Published: 17 April 2019
Last updated: 23 August 2023

History

Guidance published

Committee member list (PDF 178 KB)

Published:

23 August 2023
Equality impact assessment Final (PDF 150 KB)

Published:

23 August 2023
Consultation comments and responses (PDF 357 KB)

Published:

04 October 2023

Stakeholder list updated

Stakeholder list (PDF 139 KB)

Published:

22 August 2023

Committee meetings

Committee meeting
Minutes 1 (PDF 253 KB)

Published:

06 March 2023
Minutes 2 (PDF 245 KB)

Published:

03 May 2023
Minutes 3 (PDF 191 KB)

Published:

25 July 2023

Draft guidance consultation

Draft guidance consultation
Equality impact assessment (PDF 119 KB)

Published:

04 July 2023
Evidence review (PDF 639 KB)

Published:

04 July 2023
Supporting documentation (PDF 160 KB)

Published:

04 July 2023
Committee member list (PDF 178 KB)

Published:

04 July 2023
Comments form (MSWord 42 KB)

Published:

04 July 2023

Scope published

Final scope (PDF 184 KB)

Published:

14 July 2023

Declaration of interests

Register of interests (PDF 607 KB)

Published:

22 August 2023

Update on 24 November 2021

Declaration of interests
Register of interests (PDF 514 KB)

Published:

24 November 2021
Guidance published
Consultation comments and responses (PDF 348 KB)

Published:

24 November 2021
Supporting documentation NGA staff list (PDF 165 KB)

Published:

24 November 2021
Committee member list (PDF 162 KB)

Published:

24 November 2021
Equality impact assessment 4 (PDF 115 KB)

Published:

24 November 2021
Stakeholder list updated
Stakeholder list (PDF 171 KB)

Published:

23 November 2021
Equality and health inequalities assessment
Equality impact assessment 4 (PDF 115 KB)

Published:

15 October 2021
Draft guidance consultation
Draft guidance consultation
Draft guideline (PDF 389 KB)

Published:

20 July 2021
Evidence review C (PDF 799 KB)

Published:

20 July 2021
Committee member list (PDF 161 KB)

Published:

20 July 2021
Comments form (MSWord 37 KB)

Published:

20 July 2021
Equality impact assessment (PDF 121 KB)

Published:

20 July 2021
Supporting documentation 1 (PDF 431 KB)

Published:

20 July 2021
Supporting documentation 2 (PDF 155 KB)

Published:

20 July 2021
Pre-consultation documents released
Review questions (PDF 155 KB)

Published:

16 June 2021
Committee list updated
Committee member list (PDF 161 KB)

Published:

15 June 2021
Committee meeting
Minutes 1 (GC14) (MSWord 112 KB)

Published:

15 February 2021
Minutes 2 (GC16) (PDF 167 KB)

Published:

03 March 2021
Minutes 3 (GC17) (PDF 183 KB)

Published:

11 May 2021
Minutes 4 (GC21) (PDF 199 KB)

Published:

31 August 2021

Original development on 17 April 2019

Stakeholder list updated
Stakeholder list (PDF 126 KB)

Published:

17 April 2019
Declaration of interests
Register of interests (PDF 659 KB)

Published:

17 April 2019
Guidance published
Equality impact assessment 4 (PDF 106 KB)

Published:

17 April 2019
Consultation comments and responses (PDF 562 KB)

Published:

17 April 2019
Committee member list (PDF 138 KB)

Published:

17 April 2019
Equality and health inequalities assessment
Equality impact assessment 4 (PDF 105 KB)

Published:

06 March 2019
Draft guidance consultation
Draft guidance consultation
Draft guideline (PDF 568 KB)

Published:

19 December 2018
Equality impact assessment 3 (PDF 137 KB)

Published:

19 December 2018
Evidence review A (PDF 2.58 MB)

Published:

19 December 2018
Evidence review B (PDF 1.32 MB)

Published:

19 December 2018
Supporting documentation 1 (PDF 602 KB)

Published:

19 December 2018
Supporting documentation 2 (PDF 202 KB)

Published:

19 December 2018
Comments form (MSWord 35 KB)

Published:

19 December 2018
Committee list updated
Committee member list (PDF 177 KB)

Published:

18 December 2018
Committee meeting
Minutes 1 (PDF 389 KB)

Published:

02 February 2018
Minutes 2 (PDF 320 KB)

Published:

02 May 2018
Minutes 3 (PDF 315 KB)

Published:

23 July 2018
Minutes 4 (PDF 263 KB)

Published:

05 September 2018
Minutes 5 (PDF 260 KB)

Published:

01 November 2018
Minutes 6 (PDF 206 KB)

Published:

11 December 2018
Minutes 7 (PDF 212 KB)

Published:

29 January 2019